Destination Wealth Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Destination Wealth Management’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,216	Closed	-$5.68K	–	222
2023 Q2	$5.68K	Hold	13,216	–	–	﹤0.01%	201
2023 Q1	$6.44K	Hold	13,216	–	–	﹤0.01%	207
2022 Q4	$9.01K	Hold	13,216	–	–	﹤0.01%	198
2022 Q3	$36K	Buy	+13,216	New	+$108K	﹤0.01%	185

Destination Wealth Management's APGN Position: Q3 2023 in Review

Destination Wealth Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 13,216 shares — an estimated $5.68K sold.

Destination Wealth Management first reported a position in APGN in Q3 2022 and held it in 4 quarters. The position peaked at $36K in Q3 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

Destination Wealth Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Destination Wealth Management sold 13,216 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $5.68K.
Destination Wealth Management first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Destination Wealth Management's Apexigen, Inc. Common Stock position peaked at $36K in Q3 2022.
0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Destination Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.